Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease

Overview of attention for article published in New England Journal of Medicine, October 2019

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news: 62 news outlets
blogs: 7 blogs
policy: 2 policy sources
twitter: 946 X users
patent: 9 patents
facebook: 15 Facebook pages
wikipedia: 5 Wikipedia pages

reddit: 2 Redditors
f1000: 1 research highlight platform
q&a: 1 Q&A thread
guideline: 1 clinical guideline source
bluesky: 1 Bluesky user
podcasts: 4 podcasts

Readers on

mendeley: 924 Mendeley

So far, Altmetric has seen 17 public wall posts from 15 users.

The Unofficial Guide to Medicine, 10 Mar 2020

UGTM Presents: “Expand Your Horizons!” A 3-part mini-series on some remarkable breakthroughs in the medical world in 2019. …

Neurogenetica Clinica Pisa, 05 Nov 2019

Appena uscito sul NEJM Oligonucleotide Therapy for a Rare Genetic Disease

Scientific Information & News, 27 Oct 2019

A child with a neuronal ceroid lipofuscinosis was found to carry loss-of-function mutations in the gene MFSD8 (CLN7). A year…

PPG Oncologia e Ciências Médicas - UFPA, 27 Oct 2019

Original Article from The New England Journal of Medicine — Patient-Customized Oligonucleotide Therapy for a Rare Genetic…

This page shows the most recent Facebook posts that mention this research output. Click here to find out how to access more activity, including 13 additional Facebook posts.